可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Christopher N.Management of cardiopulmonary arrest[J].Veter Tech,2008,29(11):671-674.
[2]张松涛,李 毅,刘迎雪,等.基于Web of Science的心脏性猝死研究论文文献计量分析[J].心脏杂志,2011,23(6):830-832.
[3]Jong H,Tincate P,Reitsma R,et al.Myocardal ischemia and reperfusion injury: studies using transgenic and knockout mice[J].Current Genomics,2005,6(6):449-460.
[4]Schoenmakers SH,Spdk CA.Blood coagulation factors as inflammatory mediators[J].Blood Cells,2005,34(1):30-37.
[5]Endmary K,Shabbir M,Jia L,et al.Successful post-resuscitation tretment: key to post-cardiac arrest survival[J].Innovation,2008,8(2):10-14.
[6]常舒婷,谢 娟.两种活血针剂治疗心绞痛临床疗效比较[J].心脏杂志,2011,23(4):560-561.
[7]常联嬴,朱 彦,高秀梅.丹红注射液抗血栓作用研究进展[J].天津中医药大学学报,2013,32(4):246-249.
[8]Bottiger B,Martin E.Thrombolytic therapy during cardiopulmonary resuscitation and the role of coagulation activation after cardiac arrest[J].Current Opinion,2001,7(3):176-183.
[9]Bode C,Kern S,Gries A,et al.Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial[J].The Lancet,2001, 357(9268):1583-1585.